Status
Conditions
Treatments
About
The purpose of this prospective, randomized, controlled study is to evaluate the safety and efficacy of a new hemostatic device (HEMOBLAST™ Bellows) compared to a control device, absorbable gelatin sponge USP with thrombin.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
• Subject is undergoing an elective open cardiothoracic, abdominal, or orthopedic lower extremity surgery;
Exclusion criteria
• Subject is undergoing a laparoscopic, thoracoscopic, or robotic surgical procedure;
Intraoperative Eligibility Criteria:
Primary purpose
Allocation
Interventional model
Masking
258 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal